Paul Kentor, MD
Allergy · Highland Park, ILNPI 1538146758
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $432 of the $613 with a category attached, or 70.4%. It is spread thinly across 12 manufacturers, the largest accounting for just 18.1%. That places this record below the midpoint for allergy clinicians in IL, where the typical reported total is $1,650.
Across 24 payments — averaging $25.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$111
- Regeneron Healthcare Solutions, Inc.$111
- GSK$80
- Sanofi$71
- AbbVie$51
- Insmed, Inc.$45
- plus $145 from 6 others
What the payments were for
- Food & beverage$43270%
- Education$18130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 3 | $111 |
| Regeneron Healthcare Solutions, Inc. | 2 | $111 |
| GSK | 4 | $80 |
| Sanofi | 3 | $71 |
| AbbVie(2 entities) | 3 | $51 |
| Insmed, Inc. | 1 | $45 |
| Genentech USA, Inc. | 2 | $38 |
| Novartis | 2 | $38 |
| Blueprint Medicines Corporation | 1 | $26 |
| Optinose US, Inc. | 1 | $18 |
| Alk-abello, Inc | 1 | $14 |
| QOL Medical, LLC | 1 | $11 |
How this compares
$613 in reported general payments places this provider in the 30th percentile of 47 allergy providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spiriva RespimatTiotropium Bromide | 73 | $87,672 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 58 | $68,159 |
| Breo ElliptaFluticasone/Vilanterol | 87 | $62,199 |
| Arnuity ElliptaFluticasone Furoate | 98 | $39,596 |
| Fluticasone Propionate HfaFluticasone Propionate | 71 | $27,579 |
| Qvar RedihalerBeclomethasone Dipropionate | 48 | $25,617 |
| Wixela InhubFluticasone Propion/Salmeterol | 111 | $24,212 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 78 | $20,737 |
| Pulmicort FlexhalerBudesonide | 33 | $17,179 |
| Atrovent HfaIpratropium Bromide | 24 | $17,089 |
| Advair HfaFluticasone Propion/Salmeterol | 33 | $16,777 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 22 | $14,896 |
| DuleraMometasone/Formoterol | 28 | $14,855 |
| SymbicortBudesonide/Formoterol Fumarate | 39 | $14,030 |
| Serevent DiskusSalmeterol Xinafoate | 22 | $12,993 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta, Incruse Ellipta | $80 | $175,816256 claims |
| AstraZenecaPulmicort Flexhaler, Symbicort | $111 | $31,20972 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 47 allergy providers in Illinois.
Other allergy in Highland Park
- Ewa SchaferGlenview$165K
- Brian RotskoffChicago$82K
- Bruce BochnerChicago$43K
- Mark MillerHoffman Estates$17K
- Mohammad GhaniWestchester$16K
- Sai NimmagaddaOrland Park$14K
- Archana NarayanJoliet$11K
- Alan ResnickOrland Park$9K
- Alex ThomasChicago$9K
- Lee SoninSchaumburg$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.